Anne Grobler

Anne Grobler

Auto-generated profile, based on publicly available information

Anne Grobler

DST/NWU Preclinical Drug Development Platform, North-West University, Potchefstroom, 2520, South Africa

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2006 in Biochemical Journal
Verified
Journal Article
Closed access
FRFimmie Reinecke
Fimmie Reinecke
OLOksana Levanets
Oksana Levanets
YOYolanda Olivier
Yolanda Olivier
RLRoan Louw
Roan Louw
BSBoitumelo Semete
Boitumelo Semete
FWFrancois H. Van Der Westhuizen
Francois H. Van Der Westhuizen
The role of MT (metallothionein) gene expression was investigated in rotenone-treated HeLa cells to induce a deficiency of NADH:ubiquinone oxidoreductase (complex I). Complex I deficiency leads to a diversity of cellular consequences, including production of ROS (reactive oxygen species) and apoptosis. HeLa cells were titrated with rotenone, resulting in dose-dependent decrease in complex I activity and elevated ROS production at activities lower than 33%. Expression of MT2A (MT isoform 2A), but not MT1A or MT1B RNA, was significantly inducible by rotenone (up to 7-fold), t-BHP (t-butyl hydroperoxide; 5-fold) and CdCl2 (50-fold), but not ZnCl2. Myxothiazol treatment did not elevate either ROS or MT2A levels, which supports a ROS-related mechanism for rotenone-induced MT2A expression. To evaluate the role of MT2A expression, MT2A and MT1B were overexpressed in HeLa cells and treated with rotenone. Compared with control and MT1B-overexpressing cells, ROS production was significantly lower and cell viability higher in MT2A-overexpressing HeLa cells when ROS production was enhanced by treatment with t-BHP. Mitochondrial membrane potential was noticeably less reduced in both MT-overexpressing cell lines. MT2A overexpression in rotenone-treated cells also significantly reduced or delayed apoptosis induction, as measured by caspase 3/7 activity and cytosolic nucleosome enrichment. We conclude that MT2A offers significant protection against the main death-causing consequences of rotenone-induced complex I deficiency in HeLa cells. Our results are in support of the protective role against oxidative stress ascribed to MTs and provide evidence that MT2A expression may be a beneficial downstream adaptive response in complex I-deficient cells.

1 February 2016 in Neurochemistry International
Verified
Journal Article
Closed access
MBMelinda Barkhuizen
Melinda Barkhuizen
DADavid G. Anderson
David G. Anderson
AGAnne F. Grobler
Anne F. Grobler

10 June 2016 in Molecules
Verified
Journal Article
Open access
PDF file
CRClinton Rambanapasi
Clinton Rambanapasi
JZJan Rijn Zeevaart
Jan Rijn Zeevaart
HBHylton Buntting
Hylton Buntting
CBCornelius Bester
Cornelius Bester
DKDeon Kotze
Deon Kotze
AGAnne Grobler
Anne Grobler
Colloidal suspensions of 14 nm gold nanoparticles (AuNPs) were repeatedly administered intravenously at three dose levels (0.9, 9 and 90 µg) to male Sprague Dawley rats weekly for 7 weeks, followed by a 14-day washout period. After sacrificing, the amount of gold was quantified in the liver, lungs, spleen, skeleton and carcass using neutron activation analysis (NAA). During the study, pre- and post (24 h) administration blood samples were collected from both the test and control groups, the latter which received an equal injection volume of normal saline. General health indicators were monitored together with markers of kidney and liver damage for acute and subchronic toxicity assessment. Histopathological assessments were done on the heart, kidneys, liver, lungs and spleen to assess any morphological changes as a result of the exposure to AuNPs. The mass measurements of all the groups showed a steady increase with no signs of overt toxicity. The liver had the highest amount of gold (µg) per gram of tissue after 56 days followed by the spleen, lungs, skeleton and carcass. Markers of kidney and liver damage showed similar trends between the pre and post samples within each group and across groups. The histopathological examination also showed no hepatotoxicity and nephrotoxicity. There was accumulation of Au in tissues after repeated dosing, albeit with no observable overt toxicity, kidney or liver damage.

16 July 2015 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
PDF file
ABAnkur Bhardwaj
Ankur Bhardwaj
SMShuchi Mehta
Shuchi Mehta
SYShailendra Yadav
Shailendra Yadav
SSSudheer K. Singh
Sudheer K. Singh
AGAnne Grobler
Anne Grobler
AMAbhinav Mehta
Abhinav Mehta
The present study aimed to develop lipid–polymer hybrid nanoparticles (LPNs) for the combined pulmonary delivery of isoniazid (INH) and ciprofloxacin hydrochloride (CIP HCl). Drug-loaded LPNs were prepared by the double-emulsification solvent evaporation method using the three-factor three-level Box–Behnken design. The optimized formulation had a size of 111.81 ± 1.2 nm, PDI of 0.189 ± 1.4, and PDE of 63.64 ± 2.12% for INH-loaded LPN, and a size of 172.23 ± 2.31 nm, PDI of 0.169 ± 1.23, and PDE of 68.49 ± 2.54% for CIP HCl-loaded LPN. Drug release was found to be sustained and controlled at lower pH and followed the Peppas model. The in vitro uptake study in alveolar macrophage (AM) showed that uptake of the drugs was increased significantly if administered in the form of LPN. The stability study proved the applications of adding PLGA in LPN as the polymeric core, which leads to a much more stable product as compared to other novel drug delivery systems. Spray drying was done to produce an inhalable, dry, powdered form of drug-loaded LPN. The spray-dried (SD) powder was equally capable of producing nano-aggregates having morphology, density, flowability and reconstitutibility in the range ideal for inhaled drug delivery. The nano aggregates produced by spray drying manifested their aerosolization efficiency in terms of the higher emitted dose and fine particle fraction with lower mass median aerodynamic diameter. The in vivo study using pharmacokinetic and pharmacodynamic approaches revealed that maximum internalization efficiency was achieved by delivering LPN in SD powdered forms by pulmonary route.

1 September 2012 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Nigel Aminake MakoahNigel Aminake Makoah
Nigel Aminake Makoah
AMAman Mahajan
Aman Mahajan
VKVipan Kumar
Vipan Kumar
RHRenate Hans
Renate Hans
LWLubbe Wiesner
Lubbe Wiesner
KCKelly Chibale
Kelly Chibale

1 July 2011 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Dewald SteynDewald Steyn
Dewald Steyn
LWLubbe Wiesner
Lubbe Wiesner
Lissinda du PlessisLissinda du Plessis
Lissinda du Plessis
AGAnne F. Grobler
Anne F. Grobler
PSPeter J. Smith
Peter J. Smith
AKAwie F. Kotzé
Awie F. Kotzé